DBV Technologies Announces Financing of up to $306.9 Million (EUR284.5 Million) to Advance Viaskin(R) Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
(Paris:DBV),(NASDAQ:DBVT), Chatillon, France, March 27, 2025 DBV Technologies Announces Financing of up to $306.9 Million (EUR284.5 Million) to Advance Viaskin(R) Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved DBV secures $125.5 million (EUR116.3 million) up front and up to $181.4 million (EUR168.2 million), subject to the full exercise of warrants […]